Last Updated: 05/28/2023
DOT Rules and Regulations / Part 40: Drug and Alcohol Regulations / Appendix C to Part 40—DOT Drug Testing Semi-Annual Laboratory Report to DOT
Appendix C to Part 40—DOT Drug-Testing Semi-Annual Laboratory Report to DOT
Mail, fax, or email to:
U.S. Department of Transportation, Office of Drug and Alcohol Policy and Compliance, W62–300, 1200 New Jersey Avenue SE., Washington, DC 20590, Fax: (202) 366–3897, Email: ODAPCWebMail@dot.gov.
The following items are required on each report:
Reporting Period: (inclusive dates)
Laboratory Identification: (name and address)
1. DOT Specimen Results Reported (total number)
2. Negative Results Reported (total number)
Negative (number)
Negative-Dilute (number)
3. Rejected for Testing Results Reported (total number)
By Reason
(a) Fatal flaw (number)
(b) Uncorrected Flaw (number)
4. Positive Results Reported (total number)
By Drug
(a) Marijuana Metabolite (number)
(b) Cocaine Metabolite (number)
(c) Opioids (number)
(1) Codeine (number)
(2) Morphine (number)
(3) 6–AM (number)
(4) Hydrocodone (number)
(5) Hydromorphone (number)
(6) Oxycodone (number)
(7) Oxymorphone (number)
(d) Phencyclidine (number)
(e) Amphetamines (number)
(1) Amphetamine (number)
(2) Methamphetamine (number)
(3) MDMA (number)
(4) MDA (number)
5. Adulterated Results Reported (total number)
By Reason (number)
6. Substituted Results Reported (total number)
7. Invalid Results Reported (total number)
By Reason (number)
[82 FR 52247, Nov. 13, 2017]
Related Topics:
Do you need more information?
If you need our assistance, or want to know more about Med-Stop, please use our Support contact form, send e-mail to info@med-stop.com or call at 1-(877) 633-3633